ADGM — Adagio Medical Holdings Cashflow Statement
0.000.00%
- $20.00m
- $15.49m
- $0.60m
Annual cashflow statement for Adagio Medical Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Net Income/Starting Line | -19.9 | -23.7 | -36.6 | -75 |
Depreciation | ||||
Deferred Taxes | ||||
Non-Cash Items | -0.284 | 0.436 | 7.62 | 40.3 |
Unusual Items | ||||
Other Non-Cash Items | ||||
Changes in Working Capital | 0.579 | 0.33 | 2.79 | 5.79 |
Change in Accounts Receivable | ||||
Change in Inventories | ||||
Change in Prepaid Expenses | ||||
Change in Accounts Payable | ||||
Change in Accrued Expenses | ||||
Change in Other Liabilities | ||||
Cash from Operating Activities | -19.3 | -22.4 | -25.7 | -29.5 |
Capital Expenditures | -1.27 | -0.502 | -0.34 | -1.65 |
Purchase of Fixed Assets | ||||
Purchase / Acquisition of Intangibles | ||||
Other Investing Cash Flow Items | — | 0.002 | 0 | — |
Sale of Fixed Assets | ||||
Cash from Investing Activities | -1.27 | -0.5 | -0.34 | -1.65 |
Net Issuance / Retirement of Stock | ||||
Net Issuance / Retirement of Debt | ||||
Cash from Financing Activities | 0.13 | 9.53 | 21.9 | 15.6 |
Foreign Exchange Effects | ||||
Beginning Cash Balance | ||||
Ending Cash Balance | ||||
Net Change in Cash | -20.4 | -13.3 | -4.16 | -15.3 |